About
Joel Friedman is a physician-scientist associated with Albert Einstein College of Medicine and Vascarta. He is described as a professor at Einstein and as the scientific founder and CSO of Vascarta, an Einstein start-up formed to advance his scientific work. His visible relevance to the longevity ecosystem appears to come from scientific and translational biotech activity rather than investment management.
Areas of interest
longevitybiotechpharmaceuticalshematologyhemoglobinopathiestransfusion medicineinflammationtransdermal drug deliverysickle cell diseaseaging